These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


129 related items for PubMed ID: 8236152

  • 21. [Urinary excretion of plasmin and fibrin-fibrinogen degradation products in various types of glomerulonephritis (author's transl)].
    Koyama A, Narita M, Ishida H, Fukao K, Tojo S.
    Nihon Jinzo Gakkai Shi; 1979 Sep; 21(9):1037-46. PubMed ID: 160473
    [No Abstract] [Full Text] [Related]

  • 22. [Determination of urinary fibrin-fibrinogen degradation products (FDP) in various infantile glomerular nephorapathies].
    Tamborine G, Barbieri U, Forese S, Cocconcelli P, Zervos N.
    Minerva Pediatr; 1977 Mar 10; 29(8):525-8. PubMed ID: 865431
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Effectiveness of low-dose erythropoietin in predialysis chronic renal failure patients.
    Mitwalli A, Abuaisha H, al Wakeel J, al Mohaya S, Alam AA, el Gamal H, Fayed H.
    Nephrol Dial Transplant; 1993 Mar 10; 8(10):1085-8. PubMed ID: 8272220
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Effect of recombinant human erythropoietin on soluble interleukin 2 receptor (SIL-2R) levels in haemodialysis patients.
    Altun B, Erdem Y, Haznedaroğlu I, Gürsoy M, Yasavul U, Turgan C, Cağlar S, Kirazli S.
    Nephrol Dial Transplant; 1995 Nov 10; 10(11):2164. PubMed ID: 8643199
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Practical value of the determination of urinary fibrin degradation products in the early management of renal transplants].
    André E, Kessler M, Briquel ME, Alexandre P, Hurault de Ligny B, Huriet C.
    Sem Hop; 1983 Jun 02; 59(22):1669-73. PubMed ID: 6308788
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Long-term effects on quality of life in haemodialysis patients of correction of anaemia with erythropoietin.
    Bárány P, Pettersson E, Konarski-Svensson JK.
    Nephrol Dial Transplant; 1993 Jun 02; 8(5):426-32. PubMed ID: 8393547
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Correction of anaemia in haemodialysis patients with recombinant human erythropoietin.
    Boran M, Dalva I, Yazicioğlu A, Akbay E, Cetin S.
    Int Urol Nephrol; 1993 Jun 02; 25(2):197-203. PubMed ID: 8365853
    [Abstract] [Full Text] [Related]

  • 39. [Fibrinolysis in hemodialyzed patients with chronic kidney failure].
    Kvasnicka J, Richter J, Brzák P, Bártová V.
    Cas Lek Cesk; 1988 Jul 15; 127(29):912-5. PubMed ID: 3167960
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.